Immunomedics Announces Fiscal 2017 Results And Strategic Developments; Reiterates Guidance On BLA Submission Timeline Post author:Sam Post published:August 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017 GlaxoSmithKline Poaches New CSO From Google's Calico November 8, 2017 Why Struggling MannKind is Struggling No More September 19, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017